What is the maximum recommended dose of metoprolol (beta blocker) per day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Recommended Dose of Metoprolol Per Day

The maximum recommended daily dose of metoprolol succinate (extended-release) is 200 mg once daily, while metoprolol tartrate (immediate-release) can be administered up to 400 mg daily in divided doses. 1

Metoprolol Formulations and Maximum Dosing

  • Metoprolol Succinate (Extended-Release):

    • Maximum dose: 200 mg once daily 1
    • Allows for once-daily dosing due to extended-release formulation 1, 2
    • Provides consistent beta-blockade over 24 hours without marked peaks and troughs 2
  • Metoprolol Tartrate (Immediate-Release):

    • Typically administered in divided doses due to shorter half-life 1
    • For hypertension: 100-450 mg daily in divided doses 3
    • For post-MI maintenance: 100 mg twice daily (200 mg total) 1

Condition-Specific Maximum Dosing

  • Heart Failure:

    • Target dose: 200 mg once daily (metoprolol succinate) 1
    • In clinical trials, mean dose achieved was 159 mg daily 1
    • MERIT-HF trial demonstrated significant mortality reduction with target dose of 200 mg once daily 4
  • Hypertension:

    • Dose range: 50-400 mg once daily (metoprolol succinate) 1
    • For immediate-release formulation: 100-450 mg daily in divided doses 3
  • Post-Myocardial Infarction:

    • Maintenance dose: 100 mg twice daily (metoprolol tartrate) 1
    • Initial oral therapy after IV administration: 25-50 mg every 6 hours for 48 hours 5

Important Dosing Considerations

  • Titration Protocol:

    • Start with low dose (12.5-25 mg once daily for succinate; 25-50 mg twice daily for tartrate) 1
    • Gradually increase dose every 1-2 weeks if well tolerated 1
    • For heart failure patients, initial dose should be 12.5-25 mg once daily 1
  • Special Populations:

    • Hepatic Impairment: Dosage reduction may be necessary as elimination half-life can be prolonged up to 7.2 hours 3
    • Renal Impairment: No significant dose adjustment typically needed 3
    • Poor CYP2D6 Metabolizers: May have 7-9 hour half-life versus 3-4 hours in normal metabolizers 3

Contraindications and Precautions

  • Do not initiate in patients with:

    • Signs of heart failure or low output state 5, 1
    • Increased risk for cardiogenic shock 5
    • Significant bradycardia (heart rate <50 bpm) 5
    • Hypotension (systolic BP <90 mmHg) 5
  • Use caution in patients with:

    • Chronic obstructive pulmonary disease with reactive airway component (start with low dose of 12.5 mg) 5
    • Tachycardia or Killip Class II or III, which increases risk of cardiogenic shock 5

Common Pitfalls to Avoid

  • Never abruptly discontinue metoprolol as this may precipitate angina, myocardial infarction, or arrhythmias 1
  • Avoid initiating in decompensated heart failure patients 1
  • Monitor for bradycardia, hypotension, and worsening heart failure symptoms during dose titration 1
  • For patients transitioning from immediate-release to extended-release formulation, 200 mg of metoprolol succinate CR/XL provides similar beta-blockade to 50 mg three times daily of immediate-release metoprolol 6

References

Guideline

Metoprolol Succinate Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.